OTLK
OTLK
NASDAQ · Biotechnology

Outlook Therapeutics Inc

$1.59
-0.10 (-5.92%)
As of Jun 30, 10:45 PM ET ·
OTLK News30 articles
Outlook Therapeutics Surges on FDA Review of Wet AMD Treatment
Outlook Therapeutics shares jumped 30% after the FDA accepted its resubmitted BLA for ONS-5010/LYTENAVA, setting a PDUFA target date of July 29, 2026.
Markets
Outlook Therapeutics Surges on FDA Review Progress for Lytenava
Outlook Therapeutics shares surged 26% to $0.89 as the FDA began a 60-day review of Lytenava after a successful appeal, though the stock faces Nasdaq delisting and dilution risks.
Regulation
Microsoft Soars on Russell Rebalance; AI Spending Weighs on Outlook
Microsoft (MSFT) rallied 5.71% on record volume due to Russell index rebalancing, but investors remain wary of AI spending and capex pressures on future earnings.
Markets
Uber surges 5.5% on volume spike as safety overhaul, robotaxi outlook drive debate
Uber surged 5.47% on Friday with trading volume 3.46 times its 65-day average, as investors weigh tighter U.S. background checks and robotaxi expansion.
Markets
Micron's Earnings Beat Reshapes S&P 500 Outlook Amid Cash Flow Doubts
Micron's massive earnings beat boosted S&P 500 Q2 growth estimates, but investors sold chip stocks on worries about cash flow and pricing sustainability.
Earnings
MARA Holdings Slips on Dilution Concern Despite Bullish AI-Powered Outlook
MARA Holdings fell 3% after shareholders approved an 18 million share increase, raising dilution concerns. A bullish analyst target of $24 based on AI power demand couldn't offset the uncertainty.
Crypto
Affirm surges 10% as Prime Day spending beats expectations, boosting BNPL outlook
Affirm shares surged 9.9% after Amazon Prime Day first-day sales beat forecasts, with buy now, pay later expected to finance $2.04 billion in purchases, up 5.5% year-over-year.
Markets
Hertz Slumps 28% on Weak Q2 Outlook, Used-Car Losses
Hertz shares plunged nearly 28% after warning Q2 core profit will hit low end of guidance due to used-car sale losses, with vehicle depreciation rising to ~$300/unit/month.
Earnings
Paychex Shares Slide on Tepid Fiscal 2027 Outlook Despite Q4 Beat
Paychex shares dropped 3.8% as the company's fiscal 2027 outlook signaled slower growth, overshadowing a Q4 earnings beat.
Earnings
Ambev Shares Rise on Payout, Rate Outlook, and World Cup Demand
Ambev shares rose 1.05% to 16.34 reais as a new payout and World Cup demand offset cautious rate signals. Q1 earnings showed 8.1% organic revenue growth.
Markets
Netflix Hits 52-Week Low as Meta Expands TV Reach; Analysts Question 2027 Outlook
Netflix shares dropped to a 52-week low as subscriber churn and Meta's TV expansion weigh. Analysts warn 2027 forecasts leave little room for upside.
Markets
Pfizer Shares Slip as CFO Departure Rattles Investors; 2026 Outlook Intact
Pfizer shares fell 2.7% to $25.21 after CFO Dave Denton said he will leave in August, reigniting investor concerns over succession and obesity-drug competition.
Markets
Home Depot Gains 2.1% as Housing Data Clouds Outlook
Home Depot shares climbed 2.1% in a shortened week, but soft housing data and upcoming new-home sales figures keep the outlook uncertain. The company reaffirmed its 2026 targets.
Markets
Accenture's Slashed Outlook Sinks IT Services Stocks
Accenture shares plunged 18% after cutting its fiscal 2026 sales growth outlook to 3-4%, triggering broad declines in IT services stocks and raising concerns over AI-driven growth.
Earnings
Dow Rises on Chip Rally as Oil Slips; Fed Rate Outlook Clouds Gains
The Dow gained 0.39% as chip stocks rallied on Intel's Apple deal and oil prices fell, but Fed rate concerns lingered with a 50% chance of a September hike.
Markets
Accenture Stock Dips on Weak Outlook Despite $4.18B Cybersecurity Investment
Accenture slashed its full-year revenue growth forecast and issued weak Q4 guidance, sending shares lower premarket despite a $4.18 billion cybersecurity acquisition announcement.
Earnings
Meta Slumps 5.5% as Hawkish Fed, AI Executive Departure Cloud Outlook
Meta shares plunged 5.5% on Wednesday, dragged down by a hawkish Fed signal and the departure of a top AI executive, raising questions about its AI spending.
Markets
ServiceNow Plunges as Software Stocks Sink on Hawkish Fed Outlook
ServiceNow shares plunged nearly 6% as software stocks sank on hawkish Fed rate concerns, despite a price target hike to $130 from Benchmark.
Markets
3M Stock Lags Market as Dividend Paid, Analysts Remain Split on Outlook
3M shares rose slightly to $158.32 but underperformed the market. Analysts are divided, with Bernstein bearish at $131 target, while the company's dividend and turnaround efforts are in focus.
Analysis
IREN Stock Rebounds as AI Cloud Revenue Outlook and Funding Clarity Emerge
IREN shares bounced $5.16 to $56.71 as investors assessed AI cloud prospects and funding. Needham cut 2026-27 estimates on delayed revenue ramp; mining revenue nears zero. Key catalyst: billable AI cloud revenue proof before Sep 16 earnings.
Markets
Lennar Stock Drops on Lowered Outlook Despite Earnings Beat
Lennar beat adjusted EPS estimates but cut its 2026 delivery target and issued weaker-than-expected Q3 guidance, sending shares lower after hours.
Earnings
AMD Rallies on BofA's Bullish AI CPU Outlook and Upcoming Event
AMD shares surged 8% after Bank of America lifted its price target to $560 and raised the 2030 server CPU market forecast to $170B, driven by agentic AI demand. The July Advancing AI event is now a key catalyst.
Technology
AT&T Holds Gains as Fiber Strategy and Buyback Plan Buoy Outlook
AT&T shares held near Wednesday's close after the company reiterated its 2026 and multi-year guidance, including a $4.0-$4.5 billion Q2 free cash flow target and a fiber-driven growth plan.
Markets
American Airlines Stock Slumps as Jet Fuel Costs Surge, Clouding Profit Outlook
American Airlines shares dropped 4.8% Wednesday as rising jet fuel costs threaten to erase revenue gains, with the carrier forecasting a wide EPS range for 2026.
Markets
Clover Health Surges as CMS Upgrade Boosts 2027 Outlook
Clover Health surged after CMS upgraded its main Medicare Advantage PPO contract to 4.5 stars, unlocking higher 2027 quality bonus payments. The stock jumped 14% to $4.89.
Markets
Lemonade Stock Surges on Profitability Outlook and Analyst Upgrade
Lemonade shares surged 10.6% as investors focused on the company's reiterated Q4 adjusted EBITDA target and a TD Cowen price target hike.
Earnings
Broadcom Rises as Chip Sector Rebounds; AI Demand Outlook Remains Uncertain
Broadcom shares rose 2.8% as chip stocks rebounded from a $1 trillion selloff, but the company's unchanged 2027 AI revenue forecast and Q2 revenue miss keep Wall Street cautious.
Markets
Lloyds Shares Near Pound as Buyback, Rate Cuts, and Economic Stability Shape Outlook
Lloyds Banking Group shares slipped 0.1% to 99.06p amid a share buyback and mortgage rate cuts, with CFO William Chalmers citing a stable UK outlook and forecasting net interest income above £14.9 billion for 2026.
Markets
Exxon Mobil's Stock Outlook Tied to Oil Prices and Fed Policy
Exxon Mobil stock closed lower Friday but gained for the week. Investors weigh tight oil supplies against demand destruction and upcoming inflation data that could influence Fed policy.
Commodities
Patterson-UTI Rises on Strong Drilling Outlook Despite Oil Decline
Patterson-UTI shares rose 3.1% as the company projected higher rig counts and $220M in Q2 adjusted EBITDA, despite a 3% drop in oil prices and historically low DUC wells.
Markets